Mesna—a short review
- 30 June 1987
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 14 (2), 67-86
- https://doi.org/10.1016/0305-7372(87)90041-7
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Excretion of disodium Bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosingEuropean Journal of Cancer and Clinical Oncology, 1987
- MESNA AND TOTAL BODY IRRADIATIONThe Lancet, 1987
- Protecting the Bladder from Cyclophosphamide with MesnaNew England Journal of Medicine, 1986
- Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosingEuropean Journal of Cancer and Clinical Oncology, 1985
- Sodium-2-mercaptoethanesulfonate (MESNA) and Ifosfamide NephrotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data)Cancer Treatment Reviews, 1983
- Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (Dimesna) in the ratFEBS Letters, 1982
- Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.Thorax, 1980
- Prophylaktische Alkalisierung des Harns bei zytostatischer Tumorbehandlung mit den Oxazaphosphorin-Derivaten Cyclophosphamid und IfosfamidOnkologie, 1979